Amarin (AMRN) Stock: Buy, Sell, or Hold?
AMRN - Amarin Corp Plc
$13.63
-0.08 (-0.58%)
▼
5d:
-2.43%
30d:
-4.42%
90d:
-2.15%
WAIT
LOW Confidence
Analysis Updated: Sep 4, 2026 12:00 AM ET
Earnings: Jul 29, 2026
0d
Get Alerted When AMRN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: AMRN shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: AMRN shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: AMRN is currently trading at $13.63, which is considered oversold relative to its 30-day fair value range of $13.87 to $14.30. From a valuation perspective, the stock is trading at a discount (Forward PE: -227.2) compared to its historical average (17.3). At these levels, the market is pricing in 0% annual earnings growth.
Technical Outlook: Technically, AMRN is in a downtrend. The price is currently testing key support at $13.52. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AMRN is in a downtrend. The price is currently testing key support at $13.52. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$13.87 -
$14.30
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (49/100)
- BULLISH: High volume confirmation
- BEARISH: Trading above Wall St target ($12.50)
- WARNING: Composite score 51/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$13.87 -
$14.30
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$13.52
Resistance Level
$15.25
Current Trend
Downtrend
Technical data as of
Sep 4, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-227.17
Wall Street Target
$12.50
(-8.3%)
Revenue Growth (YoY)
-42.0%
Earnings Growth (YoY)
-94.2%
Profit Margin
-14.6%
PE vs Historical
-227.2 vs 17.3
CHEAP
Share & Embed Analysis
Last updated: September 07, 2026 6:44 AM ET
Data refreshes hourly during market hours. Next update: 7:44 AM
Data refreshes hourly during market hours. Next update: 7:44 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AMRN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - General Stocks
Top-rated stocks in Drug Manufacturers - General by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LLY
Eli Lilly and Company |
STRONG BUY
31 analysts |
$1316 | 43 HOLD |
|
GILD
Gilead Sciences Inc |
BUY
30 analysts |
$157 | 39 SELL |
|
ABBV
AbbVie Inc |
BUY
28 analysts |
$277 | 51 HOLD |
|
AMGN
Amgen Inc |
HOLD
32 analysts |
$390 | 51 HOLD |
|
BIIB
Biogen Inc |
HOLD
37 analysts |
$237 | 47 HOLD |
